The Lancet. Oncology. 2020 Dec 17. pii: S1470-2045(20)30636-7. doi: 10.1016/S1470-2045(20)30636-7
|
Results from the FeDeriCa trial: are we reducing the burden of breast cancer treatment?
|
Bartsch R1, Minichsdorfer C2, Kolberg-Liedtke C3 |
 Author information
1Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria. Electronic address: rupert.bartsch@meduniwien.ac.at.
2Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
3Department of Gynecology and Obstetrics, University Hospital Essen, Essen, Germany.
|
Publikations ID: 33357419
Quelle: öffnen
|